Astex Pharma Inc., Delcath Systems Inc., BioMarin Pharma Inc., and Akorn... -- LONDON, September 30, 2013 /PRNewswire/ -- On Friday, September 27, 2013, the U.S. equity market ended on a lower note with the S&P 500 falling by 0.41% to end the day at 1,691.75; the Dow Jones Industrial Average declining by 0.46% to close at 15,258.24; and the NASDAQ Composite finishing at 3,781.59, down 0.15%. Shares in the healthcare sector ended mostly on a lower note, tracking losses in the broader market. The major movers in the sector included Astex Pharmaceuticals Inc. (NASDAQ: ASTX), Delcath Systems Inc. (NASDAQ: DCTH), BioMarin Pharmaceutical Inc. AAAResearchReports.com has completed their technical analysis on ASTX, DCTH, BMRN, and AKRX and these free reports are accessible by registering at: Shares in Astex Pharmaceuticals Inc. edged lower on Friday, tracking losses in the broader market. The company's shares fluctuated between $8.47 and $8.51 before finishing the day 0.47% lower at $8.47. A total of 5.35 million shares were traded, which is above the daily average volume of 2.86 million. Despite Friday's pullback, the company's shares have rallied 106.08% in the last three months and 23.29% in the previous one month, compared to a gain of 5.32% and 3.60% in the S&P 500 during the respective periods. Furthermore, Astex Pharmaceuticals Inc.'s stock is trading above its 50-day and 200-day moving averages of $6.63 and $4.93, respectively. Sign up for free technical research on ASTX at: Delcath Systems Inc.'s stock fell sharply on Friday, reversing all of the gains from the previous trading session. The company's shares closed the day 3.55% lower at $0.30 after fluctuating between $0.30 and $0.31 during the trading session. A total of 0.92 million shares were traded, which is below the daily average volume of 1.18 million. The company's shares have gained 0.95% in the previous three trading sessions, compared to a loss of 0.33% in the S&P 500 during the same period. Moreover, Delcath Systems Inc.'s stock is trading below its 50-day and 200-day moving averages of $0.36 and $0.93, respectively. Be sure to read our latest technical research on DCTH by registering at: On Friday, BioMarin Pharmaceutical Inc.'s stock ended the session 0.05% lower than the previous day's price of $74.13. The company's shares oscillated between $73.65 and $74.60 before closing the day at $74.09. A total of 1.26 million shares were traded, which is below the daily average volume of 1.36 million. Despite Friday's losses, the company's shares have surged 12.51% in the last one month and 32.92% in the last three months, outperforming the S&P 500 which has gained 3.60% and 5.32% during the respective periods. Additionally, BioMarin Pharmaceutical Inc.'s stock is trading above its 50-day and 200-day moving averages of $67.74 and $61.02, respectively. Sign up and read the complimentary report on BMRN at: Akorn Inc.'s shares rose sharply on Friday, extending the gains from the previous trading session. The company's shares vacillated between $18.44 and $19.22 before finishing the day 1.99% higher at $18.98. A total of 0.69 million shares were traded, which is at par with their daily average volume. The company's shares have gained 40.38% in the previous three months and 2.04% in the last three trading sessions, compared to a gain of 5.32% and a loss of 0.33% in the S&P 500 during the respective periods. Furthermore, Akorn Inc.'s stock is trading near its 52-week high of $19.47 as well as above its 50-day and 200-day moving averages of $16.72 and $14.53, respectively. The free report on AKRX can be downloaded by signing up now at: